Perhaps conditional knock-out experiments that delete BAK prior to castration, or knock-in experiments that replace WT-BAK with Y108-deficient mutants may clarify the role of BAK in apoptosis induced by androgen ablation and the role of BAK phosphorylation in apoptosis resistance in advanced prostate cancer. Here, BAK1 is linked to prostate carcinoma.